| Overview |
| bs-2685R-RBITC |
| CD134 Polyclonal Antibody, RBITC Conjugated |
| WB, IF(IHC-P), IF(IHC-F), IF(ICC) |
| Human, Mouse, Rat |
| Dog, Cow, Horse |
| Specifications |
| RBITC |
| Rabbit |
| KLH conjugated synthetic peptide derived from human TNFRSF4 |
| Polyclonal |
| #REF! |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 7293 |
| P43489 |
| Cell membrane |
| OX4; ACT35; CD134; IMD16; TXGP1L; Tumor necrosis factor receptor superfamily member 4; ACT35 antigen; OX4L receptor; TAX transcriptionally-activated glycoprotein 1 receptor; TNFRSF4 |
| Receptor for TNFSF4/OX4L/GP34. Is a costimulatory molecule implicated in long-term T-cell immunity. |
| Application Dilution |
| WB |
1:300-5000 |
| IF(IHC-P) |
1:50-200 |
| IF(IHC-F) |
1:50-200 |
| IF(ICC) |
1:50-200 |